My take is that its very difficult for a few MDs to comprehend that DCVAXL amended the SAP to RWE OS. AS AF did, they keep rehashing the trial failed because it did not meet its original PFS endpoint. I do believe the small doubt that has been sawn after JA has partially contributed to larger investment parties waiting before investing. That's why I strongly believe we see a huge increase in market cap after MHRA approval. Not because the UK is a such dominant market but because it will prove the well-respected MHRA fully accepts the amended SAP which I think will give the green light for larger investors to start buying NWBO shares.
News 
Market Data 
Discover 
AI
